Alterity Therapeutics Limited ATHE
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.28% | -51.60% | -0.32% | -97.43% | -2.11% |
| Total Depreciation and Amortization | 2.50% | 5.26% | 0.53% | -12.09% | 1.90% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.28% | 2.73% | 0.31% | 450.19% | 2.13% |
| Change in Net Operating Assets | -2.32% | 88.16% | -0.32% | -343.28% | 2.12% |
| Cash from Operations | -2.29% | -18.51% | -0.32% | -250.88% | -2.11% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -100.00% | 0.32% | 202.14% | -2.12% |
| Cash from Investing | -- | -100.00% | 0.32% | 202.14% | -2.12% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -6.34% | 0.00% | -12.59% | 0.00% |
| Issuance of Common Stock | -- | -100.00% | 0.00% | -51.68% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | 0.00% | 59.58% | 0.00% |
| Cash from Financing | -2.46% | -100.39% | 0.32% | -50.19% | 2.12% |
| Foreign Exchange rate Adjustments | 2.24% | 346.46% | -0.79% | 75.00% | -2.02% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.28% | -178.33% | 0.32% | -42.76% | 2.12% |